Miscellaneous ocular agents:

Indications for ILUVIEN:

Diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids without a significant rise in intraocular pressure.


Give by intravitreal inj. See full labeling for administration.


Not established.


Ocular or periocular infections. Glaucoma.


Monitor for increased IOP and endophthalmitis; may include check for perfusion of the optic nerve head immediately, tonometry within 30 mins, and biomicroscopy between 2–7 days post injection. Risk of secondary ocular infections (eg, bacterial, fungal, viral). History of ocular herpes simplex: not recommended. Risk of implant migration if absent or torn posterior capsule of the lens. Pregnancy (Cat.C). Nursing mothers.

Pharmacologic Class:


Adverse Reactions:

Cataract development, increased IOP; injection-related effects (eg, endophthalmitis, eye inflammation, retinal detachments), others.

How Supplied:

Single-use applicator—1 (w. needle)